×
XWELL EBIT Margin 2010-2025 | XWEL
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Profit Margins
Gross Margin
Operating Margin
EBITDA Margin
Pre-Tax Margin
Net Margin
XWELL ebit margin from 2010 to 2025. Ebit margin can be defined as earnings before interest and taxes as a portion of total revenues
View More
XWELL EBIT Margin 2010-2025 | XWEL
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Profit Margins
Gross Margin
Operating Margin
EBITDA Margin
Pre-Tax Margin
Net Margin
XWELL ebit margin from 2010 to 2025. Ebit margin can be defined as earnings before interest and taxes as a portion of total revenues
Related Stocks
Company Name
Market
Cap
Danaher (DHR)
$143.6B
CVS Health (CVS)
$83.1B
Elevance Health (ELV)
$66.2B
Cencora (COR)
$55.3B
DiDi Global (DIDIY)
$26.1B
Labcorp Holdings (LH)
$22.1B
Natera (NTRA)
$20.7B
BioMerieux (BMXMF)
$17.7B
EUROFINS SCIENT (ERFSF)
$14.9B
CochLear (CHEOY)
$13.2B
ICON (ICLR)
$12.8B
Solventum (SOLV)
$12.7B
Medpace Holdings (MEDP)
$12.2B
Viatris (VTRS)
$11.4B
Revvity (RVTY)
$10.1B
Sonic Healthcare (SKHHY)
$9B
HealthEquity (HQY)
$8B
Avantor (AVTR)
$7.8B
Caris Life Sciences,�Inc (CAI)
$7.6B
Charles River Laboratories (CRL)
$7.3B
Bausch + Lomb (BLCO)
$4.8B
Sotera Health (SHC)
$4B
Amplifon S.p.A (AMFPF)
$3.9B
BrightSpring Health Services (BTSG)
$3.7B
Surgery Partners (SGRY)
$3B
GeneDx Holdings (WGS)
$3B
Alignment Healthcare (ALHC)
$2.9B
Concentras Parent (CON)
$2.8B
Organon (OGN)
$2.4B
Progyny (PGNY)
$2B